Rights and permissions
About this article
Cite this article
IV vancomycin to oral linezolid switch potentially cost saving. Pharmacoecon. Outcomes News 425, 5 (2003). https://doi.org/10.1007/BF03276637
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276637